{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:33:52Z","timestamp":1769744032914,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaesthesia Critical Care & Pain Medicine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.accpm.2021.100847","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T13:07:43Z","timestamp":1616591263000},"page":"100847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phenotype and genotype characteristics of 58 patients showing a prolonged effect of succinylcholine: A four-year experience"],"prefix":"10.1016","volume":"40","author":[{"given":"Cl\u00e9ment","family":"Millet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Plaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Delacour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.accpm.2021.100847_bib0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.abb.2009.12.005","article-title":"Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior","volume":"494","author":"Masson","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.accpm.2021.100847_bib0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.neuint.2012.06.016","article-title":"Why has butyrylcholinesterase been retained? Structural and functional diversification in a duplicated gene","volume":"61","author":"Johnson","year":"2012","journal-title":"Neurochem Int"},{"key":"10.1016\/j.accpm.2021.100847_bib0015","first-page":"1067","article-title":"Prolonged apnoea following injection of succinylcholine","volume":"265","author":"Forbat","year":"1953","journal-title":"Lancet"},{"key":"10.1016\/j.accpm.2021.100847_bib0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1139\/y57-041","article-title":"A method for the detection of atypical forms of human serum cholinesterase; determination of dicucaine number","volume":"35","author":"Kalow","year":"1957","journal-title":"Can J Biochem Physiol"},{"key":"10.1016\/j.accpm.2021.100847_bib0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.accpm.2021.100847_bib0030","first-page":"99","article-title":"D\u00e9ficit en butyrylcholinest\u00e9rase: quelle d\u00e9marche diagnostique, quelles cons\u00e9quences pour le patient?","volume":"3","author":"Delacour","year":"2017","journal-title":"Anest Reanim"},{"key":"10.1016\/j.accpm.2021.100847_bib0035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bcp.2014.09.014","article-title":". Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), \"silent\" with mivacurium","volume":"92","author":"Delacour","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.accpm.2021.100847_bib0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.accpm.2021.100847_bib0045","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","article-title":"PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels","volume":"31","author":"Choi","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.accpm.2021.100847_bib0050","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: the human genomic variant search engine","volume":"35","author":"Kopanos","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.accpm.2021.100847_bib0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.accpm.2021.100847_bib0060","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/humu.23641","article-title":"ClinVar at five years: delivering on the promise","volume":"39","author":"Human Mutation Landrum","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.accpm.2021.100847_bib0065","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"The UniProt Consortium","year":"2019","journal-title":"Nucleid Acid Res"},{"key":"10.1016\/j.accpm.2021.100847_bib0070","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.accpm.2021.100847_bib0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/EJA.0000000000000561","article-title":"A case series of life-threatening succinylcholine-induced anaphylaxis","volume":"34","author":"Le Dorze","year":"2017","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.accpm.2021.100847_bib0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/bja\/46.4.273","article-title":"Aetiology of prolonged apnoea after suxamethonium","volume":"46","author":"Bauld","year":"1974","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.accpm.2021.100847_bib0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00000542-198012000-00017","article-title":"Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme","volume":"53","author":"Viby-Mogensen","year":"1980","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2021.100847_bib0090","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.annfar.2012.08.006","article-title":"Joyeux anniversaire succinylcholine!","volume":"31","author":"Plaud","year":"2012","journal-title":"Ann Fr Anest R\u00e9anim"},{"key":"10.1016\/j.accpm.2021.100847_bib0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.anrea.2019.07.010","article-title":"Le d\u00e9ficit en butyrylcholinest\u00e9rase plasmatique: \u00e9valuation des connaissances et de l\u2019exp\u00e9rience des praticiens en anesth\u00e9sie-r\u00e9animation","volume":"6","author":"Millet","year":"2020","journal-title":"Anesth R\u00e9anim"},{"key":"10.1016\/j.accpm.2021.100847_bib0100","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1373\/49.8.1297","article-title":"Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population","volume":"49","author":"Yen","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.accpm.2021.100847_bib0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/FPC.0000000000000221","article-title":"Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene","volume":"26","author":"Wichmann","year":"2016","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.accpm.2021.100847_bib0110","first-page":"934","article-title":"Identification of a frameshift mutation responsible for the silent phenotype of human serum cholinesterase, Gly 117 (GGT----GAG)","volume":"46","author":"Nogueira","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.accpm.2021.100847_bib0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2016.03.007","article-title":"On-site analysis of acetylcholinesterase and butyrylcholinesterase activity with the ChE check mobile test kit-Determination of reference values and their relevance for diagnosis of exposure to organophosphorus compounds","volume":"249","author":"Worek","year":"2016","journal-title":"Toxicol Lett"}],"container-title":["Anaesthesia Critical Care & Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556821000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556821000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:48:53Z","timestamp":1762480133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352556821000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2352556821000503"],"URL":"https:\/\/doi.org\/10.1016\/j.accpm.2021.100847","relation":{},"ISSN":["2352-5568"],"issn-type":[{"value":"2352-5568","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotype and genotype characteristics of 58 patients showing a prolonged effect of succinylcholine: A four-year experience","name":"articletitle","label":"Article Title"},{"value":"Anaesthesia Critical Care & Pain Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.accpm.2021.100847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise d'anesth\u00e9sie et de r\u00e9animation (Sfar). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100847"}}